MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

Protect from light. Store in an airtight container.

Provenance

This compatibility recommendation is derived from Promazine 25mg tablets (Teva UK Ltd).

Stability Notes

Protect from light. Store in an airtight container.

Provenance

This compatibility recommendation is derived from Promazine 25mg tablets (Teva UK Ltd).

Stability Notes

Protect from light. Store in an airtight container.

Provenance

This compatibility recommendation is derived from Promazine 25mg tablets (Teva UK Ltd).

Stability Notes

Protect from light. Store in an airtight container.

Provenance

This compatibility recommendation is derived from Promazine 25mg tablets (Teva UK Ltd).

Stability Notes

Protect from light. Store in an airtight container.

Provenance

This compatibility recommendation is derived from Promazine 50mg tablets (Teva UK Ltd).

Stability Notes

Protect from light. Store in an airtight container.

Provenance

This compatibility recommendation is derived from Promazine 50mg tablets (Teva UK Ltd).

Stability Notes

Protect from light. Store in an airtight container.

Provenance

This compatibility recommendation is derived from Promazine 50mg tablets (Teva UK Ltd).

Stability Notes

Protect from light. Store in an airtight container.

Provenance

This compatibility recommendation is derived from Promazine 50mg tablets (Teva UK Ltd).

Stability Notes

Protect from light. Store in airtight containers.

Provenance

This compatibility recommendation is derived from Phenergan 10mg tablets (Sanofi).

Stability Notes

Protect from light. Store in airtight containers.

Provenance

This compatibility recommendation is derived from Phenergan 10mg tablets (Sanofi).

Stability Notes

Protect from light. Store in airtight containers.

Provenance

This compatibility recommendation is derived from Phenergan 10mg tablets (Sanofi).

Print this list

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.
Medicines under this category are not suitable for use inside MCAs.
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.